Aberrant Promoter Methylation of YAP Gene and its Subsequent Downregulation in Indian Breast Cancer Patients
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Aberrant Promoter Methylation of YAP Gene and its Subsequent Downregulation in Indian Breast Cancer Patients
Authors
Keywords
Downregulation, Hippo pathway, mRNA, Tumor suppressor gene, YAP
Journal
BMC CANCER
Volume 18, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-07-03
DOI
10.1186/s12885-018-4627-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Promoter methylation of yes-associated protein (YAP1) gene in polycystic ovary syndrome
- (2017) Li-Le Jiang et al. MEDICINE
- YAP1 inhibition radiosensitizes triple negative breast cancer cells by targeting the DNA damage response and cell survival pathways
- (2017) Daniel Andrade et al. Oncotarget
- Aberrant promoter methylation of cancer-related genes in human breast cancer
- (2016) Liang Wu et al. Oncology Letters
- The Hippo transducers TAZ and YAP in breast cancer: oncogenic activities and clinical implications
- (2015) Marcello Maugeri-Saccà et al. EXPERT REVIEWS IN MOLECULAR MEDICINE
- Hippo pathway in mammary gland development and breast cancer
- (2014) P. Shi et al. ACTA BIOCHIMICA ET BIOPHYSICA SINICA
- YAP Expression in Normal and Neoplastic Breast Tissue: An Immunohistochemical Study
- (2014) Yolanda Jaramillo-Rodríguez et al. ARCHIVES OF MEDICAL RESEARCH
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- The dual functions of YAP-1 to promote and inhibit cell growth in human malignancy
- (2013) Hai Wang et al. CANCER AND METASTASIS REVIEWS
- Control of the Hippo Pathway by Set7-Dependent Methylation of Yap
- (2013) Menno J. Oudhoff et al. DEVELOPMENTAL CELL
- Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
- (2013) J. Gao et al. Science Signaling
- Mammalian Hippo signalling: a kinase network regulated by protein–protein interactions: Figure 1
- (2012) Alexander Hergovich BIOCHEMICAL SOCIETY TRANSACTIONS
- Comprehensive molecular portraits of human breast tumours
- (2012) Daniel C. Koboldt et al. NATURE
- The Hippo pathway target, YAP, promotes metastasis through its TEAD-interaction domain
- (2012) J. M. Lamar et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Structures of YAP protein domains reveal promising targets for development of new cancer drugs
- (2012) Marius Sudol et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.
- (2012) Ethan Cerami et al. Cancer Discovery
- Loss of Yes-associated protein (YAP) expression is associated with estrogen and progesterone receptors negativity in invasive breast carcinomas
- (2011) Rozina Tufail et al. BREAST CANCER RESEARCH AND TREATMENT
- Molecular biology in breast cancer: Intrinsic subtypes and signaling pathways
- (2011) Pilar Eroles et al. CANCER TREATMENT REVIEWS
- Cancer genomics: from discovery science to personalized medicine
- (2011) Lynda Chin et al. NATURE MEDICINE
- Yes-associated protein (YAP) functions as a tumor suppressor in breast
- (2008) M Yuan et al. CELL DEATH AND DIFFERENTIATION
- TEAD mediates YAP-dependent gene induction and growth control
- (2008) B. Zhao et al. GENES & DEVELOPMENT
- Expression of Yes-associated protein in common solid tumors
- (2008) Angela A. Steinhardt et al. HUMAN PATHOLOGY
- Mst2 and Lats Kinases Regulate Apoptotic Function of Yes Kinase-associated Protein (YAP)
- (2008) Tsutomu Oka et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More